Andrew Hudson

机构：The Christie Hospital, The Christie NHS Foundation Trust · ORCID：0000-0002-1377-6735

发表论文 57 篇 · 总被引 645 次 · h-index 10

代表论文

• Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol (2025 · The Lancet Oncology · 被引 24)
• EPIC-A: Phase II trial of cemiplimab plus standard of care chemotherapy followed by maintenance cemiplimab in locally advanced or metastatic penile carcinoma. (2025 · Journal of Clinical Oncology · 被引 11)
• PETRANHA: Phase 1/2 study of AZD5305 + novel hormonal agents in patients with metastatic prostate cancer–Interim safety and pharmacokinetic results. (2024 · Journal of Clinical Oncology · 被引 9)
• EPIC-B: Phase II trial of cemiplimab as first-line treatment in advanced penile carcinoma. (2025 · Journal of Clinical Oncology · 被引 7)
• 2384MO First interim efficacy analysis of the phase I/II PETRANHA trial of saruparib + androgen receptor pathway inhibitors (ARPI) in patients (pts) with metastatic prostate cancer (mPC) (2025 · Annals of Oncology · 被引 1)
• Avelumab first-line (1L) maintenance therapy for advanced urothelial cancer: real-world early clinical experience in the UK (2023 · European Urology Open Science · 被引 1)